language_icon
EN
HI

Jagsonpal Pharmaceuticals Share price

JAGSNPHARM

185

6.09 (3.40%)
NSE
BSE
Last updated on 13 Jan, 2026 | 15:29 IST
alert_iconwatchlist_icon
BUYSELL
Today's High

185.00

Today's Low

179.01

52 Week Low

179.01

52 Week High

665.75

alert_iconThe current prices are delayed, login to your account for live prices

Jagsonpal Pharmaceuticals Chart

Jagsonpal Pharmaceuticals Share Key Metrics

Volume
21767.00
Market Cap
1194.78 CR
LTQ@LTP
8@185.00
ATP
181.63
Var Margin
24.37 %
Circuit Range
143.13-214.69
Delivery %
38.58 %
Value
39.54 L
ASM/GSM
No
Market Lot
1

Summary

At 13 Jan, 2026 | 15:29, Jagsonpal Pharmaceuticals share price stands at ₹185, showing a 6.09% 3.40 for the day. The stock’s intraday movement has stayed between ₹179.01 and ₹185.00, while on a 52-week basis it has fluctuated from ₹179.01 to ₹665.75.
In terms of trading activity, Jagsonpal Pharmaceuticals has recorded a volume of 21767 shares, with a market capitalisation of ₹66781270. The stock’s Average Traded Price (ATP) stands at ₹18163, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 8,18500. The stock operates within a circuit range of ₹143.13-214.69, with a Value of ₹39.54 L. The Delivery Percentage for the day is 38.58%. Additionally, Jagsonpal Pharmaceuticals currently falls under the No framework, and trades with a market lot size of 1.

Jagsonpal Pharmaceuticals Fundamentals

View More
P/E Ratio

0

P/B Ratio

0

Div. Yield

0

Sector P/E

69.86

Sector P/B

0.96

Sec. Div. Yield

0.57

Jagsonpal Pharmaceuticals Resistance and Support

Pivot 217.94

Resistance

First Resistance

221.91

Second Resistance

229.37

Third Resistance

233.34

Support

First Support

210.48

Second Support

206.51

Third Support

199.05

Jagsonpal Pharmaceuticals Futures & Options

Data Not Found

Jagsonpal Pharmaceuticals Shareholding Pattern

View More
  • 2016-17
  • 2018-19
  • 2019-20
  • 2020-21
  • 2021-22
  • 2022-23
  • 2023-24
  • 2024-25
  • 2025-26
Total Promoters
Segment
Percent

Total Promoters

68.48%

Mutual Fund

0%

Insurance

0%

Foreign Institutional Investors

0.53%

Domestic Institutional Investors

0.82%

Retail

30.17%

Others

0%

Total Promoters
MAR '23
68.71%
JUN '23
68.71%
SEP '23
68.71%
DEC '23
68.48%

Jagsonpal Pharmaceuticals Corporate Actions

DateAgenda
2025-11-03Quarterly Results
2025-07-26Quarterly Results
2025-05-06Audited Results & Final Dividend
2025-01-22Quarterly Results

Jagsonpal Pharmaceuticals News

Jagsonpal Pharmaceuticals to sell Faridabad facility to Regalia Laminates for Rs 41 crore

Jul 26 2024 08:05:28
Read More

About Jagsonpal Pharmaceuticals

NSE : 4410  
BSE : 507789  
ISIN : INE048B01035  

Jagsonpal Pharmaceuticals Management

NamePosition
Mr. Rajpal Singh Kochhar Chairman Emeritus
Mr. Harsha Raghavan Chairman & Non-Exe.Director
View More

Jagsonpal Pharmaceuticals FAQs

The Buying Price of Jagsonpal Pharmaceuticals share is 185 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.

To buy Jagsonpal Pharmaceuticals stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Jagsonpal Pharmaceuticals, choose your preferred order type, and place the trade.

The Price-to-earnings (P/E) ratio of Jagsonpal Pharmaceuticals shares is 0. You can compare it with the sector average for relative valuation.

The Price to Book (P/B) ratio Jagsonpal Pharmaceuticals shares is 0. Useful to assess the stock's value relative to its book value.

To assess Jagsonpal Pharmaceuticals’s valuation compare Sector P/E, P/B which are 69.86 & 0.96 with sector averages, along with growth rates and financial metrics.

The Market Cap of Jagsonpal Pharmaceuticals is 1194.78 CR. It indicates the company's size category and trading liquidity.

The 52 week high and low prices of Jagsonpal Pharmaceuticals share price is 665.75 & 179.01. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.

Jagsonpal Pharmaceuticals belongs to the Healthcare sector.